While the Biden administration’s proposal to address drug shortages does not exempt certain drug products from 340B pricing like the [...] …
Category: Trade Association
Stakeholders disagreed on whether Congress should codify a new 340B patient definition or restrict how providers use 340B savings, in [...] …
Eighty-five percent of DSH hospitals earned more in estimated 340B revenue in 2022 than they incurred in charity care costs, [...] …
Less than four days remain for stakeholders to comment on the highly anticipated bipartisan senate draft 340B program overhaul, and [...] …
Despite the increase in the amount of 340B program drug discounts, those only amounted to 3.1% of global and 7% [...] …
A University of California at Berkeley academic is proposing a series of major reforms to the 340B discount drug program [...] …
A national hospital advocacy group “insists” multiple television stations remove a dark money group’s political ads alleging federal funding for [...] …
The drugmakers that sued to block Louisiana’s 340B contract pharmacy law “want to have their cake and eat it too,” [...] …
The Centers for Medicare & Medicaid Services (CMS) will direct Medicare administrative contractors (MACs) to provide some accelerated payments to [...] …
Building America’s Future, a nonprofit advocacy group that previously focused on trade, infrastructure, and tobacco issues, recently pushed into drug [...] …